RNA, U2 small nuclear 56, pseudogene (RNU2-56P)

RNA, U2 small nuclear 56, pseudogene (RNU2-56P) is a human non-coding RNA gene annotated as a pseudogene belonging to the family of U2 small nuclear RNAs[1][3]. U2 snRNAs are normally core components of the major spliceosome, which catalyzes splicing of pre-mRNA. While functional U2 snRNA genes (such as RNU2-1 and the previously mischaracterized pseudogene RNU2-2P/RNU2-2[2][3]) have established roles and have been studied in disease contexts, RNU2-56P is annotated strictly as a pseudogene. There is currently no experimental evidence supporting either a biological role or therapeutic relevance for RNU2-56P, nor any known association with disease. RNU2-56P appears primarily in gene annotation databases, and not in functional, mechanistic, or drug development literature[1][3]. Summary of Key Limitations: - No evidence of RNU2-56P being a functional gene or therapeutic target. - Information on RNU2-56P is absent from the main biomedical literature; listed only in gene card annotations[1][3]. - No experimental, biological, disease, or pharmacological relevance identified. - Entry may reflect gene annotation data rather than genuine molecular biology. *For structured data or therapeutic relevance, refer to U2 snRNA family genes (e.g., RNU2-1, RNU2-2/RNU2-2P) which have been shown to play critical roles in splicing and Mendelian disease, but not to RNU2-56P[2][3].*

Other names

RNU2-56PRNA, U2 small nuclear 56, pseudogeneU2 small nuclear RNA pseudogene 56